• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Gates Foundation Mastercard Wellcome coronavirus
Newsletters
A powerhouse trio pledges up to $125 million to fight coronavirus
By Sy MukherjeeMarch 10, 2020
Coronavirus Research Work
Health
Gates Foundation, Mastercard, and Wellcome team up to fuel coronavirus drug development
By Sy MukherjeeMarch 10, 2020
Coronavirus fake treatments
Newsletters
Beware the coronavirus snake oil salesmen
By Sy MukherjeeMarch 9, 2020
CVS Aetna coronavirus testing
Newsletters
CVS will waive out-of-pocket costs related to coronavirus testing and telemedicine visits
By Sy MukherjeeMarch 6, 2020
Coronavirus death rate
Health
What the rising coronavirus death rate really means
By Sy MukherjeeMarch 5, 2020
CRISPR blindness trial
Newsletters
CRISPR has a milestone moment in treating blindness
By Sy MukherjeeMarch 5, 2020
Coronavirus test
Newsletters
The coronavirus testing conundrum
By Sy MukherjeeMarch 4, 2020
Testing for coronavirus should be free, but it’s not always that simple
Health
Testing for coronavirus should be free, but it’s not always that simple
By Sy MukherjeeMarch 3, 2020
Amazon Alexa medications
Newsletters
Amazon’s Alexa can now give you detailed information on your medications
By Sy MukherjeeMarch 3, 2020
George Scangos coronavirus czar biotech
Newsletters
Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response
By Sy MukherjeeMarch 2, 2020
Biogen Sangamo Alzheimers gene therapy
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By Sy MukherjeeFebruary 28, 2020
Gilead coronavirus trial
Newsletters
Can Gilead tame the coronavirus?
By Sy MukherjeeFebruary 27, 2020
Gilead remdesivir clinical trials
Health
Gilead’s coronavirus treatment is barreling its way into new clinical trials
By Sy MukherjeeFebruary 26, 2020
Apple J&J heart study
Newsletters
Apple and Johnson & Johnson team up on heart study
By Sy MukherjeeFebruary 26, 2020
COVID-19-Coronavirus-microscope
Health
The first U.S. trial for a coronavirus treatment has started
By Sy MukherjeeFebruary 25, 2020
1...
  • 18
  • 19
  • 20
  • 21
  • 22
...100
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Success
Even as Elon Musk calls philanthropy ‘very hard,’ every day Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our and Privacy Policy |  | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.